Approximately 5%‐10% and 20% of breast and ovarian cancer cases are considered hereditary tumors,3, 4 but only 25% of HBOC are associated with BRCA1/2 pathogenic variants, which affect DNA repair mechanisms.5 This evidence concerns the gene BRCA1 and ovarian carcinoma.